Attendees at The Liver Meeting® will have the unique opportunity to participate in the development of an alternative payment model for cirrhosis at this year’s Value-based Medicine in Hepatology session on Sunday.
“Not only will they learned about value-based care, but they’ll be able to provide their opinions and that will actually influence public policy,” said co-chair Michael L Volk MD, MSc, Division Head of Gastroenterology/Hepatology at Loma Linda Medical Center. Meena B. Bansal, MD, FAASLD, Associate Professor of Medicine at Mount Sinai School of Medicine, is co-chair of the session.
Dr. Volk noted that the series of Value-Based Medicine sessions at The Liver Meeting® the past couple of years have focused on cirrhosis because of its significant morbidity and mortality and its high cost to the healthcare system.
“Cirrhosis kills as many people as diabetes or kidney disease, and it costs the healthcare system about $20 billion dollars, which is about as much as heart failure,” said Dr. Volk. “So as the US healthcare system is shifting from fee for service to more value-based care, cirrhosis is an ideal target. As the last several years have progressed, I’ve tried to take the series from being more theoretical to more practical and focused on things that can be used in day to day practice.”
The session will kick off with a general overview provided by Dr. Volk and followed by a look at how alternative pay models work in other chronic disease states by Ziad F. Gellad, MD, MPH, AGAF, associate professor of medicine in the Division of Gastroenterology at Duke University Medical Center and a faculty member of the Duke Clinical Research Institute.
“Rather than trying to reinvent the wheel, we can see what’s worked in other similar chronic conditions,” said Dr. Volk, who noted that alternative payment models are very new for chronic conditions.
The session will also include payer and health system perspectives, followed by breakout sessions where attendees will work together on how to create the alternative payment model.
“The AASLD is currently funding a nationwide collaborative that’s trying to develop an alternative payment model, so we are using this as a working group. Participants will actually be able to contribute to development of an actual alternate payment model so their input will matter,” said Dr. Volk.
He added that the collaborative is currently creating a software platform that will be pilot tested at 10 sites. This infrastructure will then be used to support alternative payment models.
“In late 2019, we expect to convene a small consensus conference or stakeholder conference to talk about implementing alternative payment models. We’re looking to have about three center/insurer dyads. If that’s successful then we would move onto getting it approved through CMS for Medicare,” he explained.